Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 501262, 15 pages
http://dx.doi.org/10.1155/2015/501262
Research Article

Identification of Subtype Specific miRNA-mRNA Functional Regulatory Modules in Matched miRNA-mRNA Expression Data: Multiple Myeloma as a Case

1College of Bioinformatics Science and Technology, Harbin Medical University, 194 Xuefu Road, Harbin 150081, China
2Department of Mathematics, Heilongjiang Institute of Technology, Harbin 150050, China

Received 17 July 2014; Revised 19 October 2014; Accepted 27 October 2014

Academic Editor: Lei Chen

Copyright © 2015 Yunpeng Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. E. A. Miska, “How microRNAs control cell division, differentiation and death,” Current Opinion in Genetics & Development, vol. 15, no. 5, pp. 563–568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Hayes, P. P. Peruzzi, and S. Lawler, “MicroRNAs in cancer: biomarkers, functions and therapy,” Trends in Molecular Medicine, vol. 20, no. 8, pp. 460–469, 2014. View at Google Scholar
  4. G. Di Leva and C. M. Croce, “Roles of small RNAs in tumor formation,” Trends in Molecular Medicine, vol. 16, no. 6, pp. 257–267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Pichiorri, L. De Luca, and R. I. Aqeilan, “MicroRNAs: new players in multiple myeloma,” Frontiers in Genetics, vol. 2, p. 22, 2011. View at Google Scholar
  6. F. Pichiorri, S.-S. Suh, M. Ladetto et al., “MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 12885–12890, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Croce and G. A. Calin, “miRNAs, cancer, and stem cell division,” Cell, vol. 122, no. 1, pp. 6–7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Jin, W. Tuo, H. Lian, Q. Liu, X.-Q. Zhu, and H. Gao, “Strategies to identify microRNA targets: new advances,” New Biotechnology, vol. 27, no. 6, pp. 734–738, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Voorhoeve, “MicroRNAs: oncogenes, tumor suppressors or master regulators of cancer heterogeneity?” Biochimica et Biophysica Acta, vol. 1805, no. 1, pp. 72–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Hiddingh, R. S. Raktoe, J. Jeuken et al., “Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis,” Scientific Reports, vol. 4, p. 5260, 2014. View at Google Scholar
  12. V. Jayaswal, M. Lutherborrow, D. D. F. Ma, and Y. H. Yang, “Identification of microRNA-mRNA modules using microarray data,” BMC Genomics, vol. 12, article 138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-G. Joung and Z. Fei, “Identification of microRNA regulatory modules in Arabidopsis via a probabilistic graphical model,” Bioinformatics, vol. 25, no. 3, pp. 387–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-G. Joung, K.-B. Hwang, J.-W. Nam, S.-J. Kim, and B.-T. Zhang, “Discovery of microRNA-mRNA modules via population-based probabilistic learning,” Bioinformatics, vol. 23, no. 9, pp. 1141–1147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Liu, J. Li, and A. Tsykin, “Discovery of functional miRNA-mRNA regulatory modules with computational methods,” Journal of Biomedical Informatics, vol. 42, no. 4, pp. 685–691, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Yoon and G. de Micheli, “Prediction of regulatory modules comprising microRNAs and target genes,” Bioinformatics, vol. 21, supplement 2, pp. ii93–ii100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Zhang, C. Li, J. Li et al., “Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure,” PLoS ONE, vol. 9, no. 5, Article ID e96908, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Xiao, Y. Ping, H. Fan et al., “Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma,” Neuro-Oncology, vol. 15, no. 7, pp. 818–828, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Peng, Y. Li, K.-A. Walters et al., “Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers,” BMC Genomics, vol. 10, article 373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Bryan, M. Terrile, I. M. Bray et al., “Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysis,” Nucleic Acids Research, vol. 42, no. 3, article e17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Avet-Loiseau, F. Magrangeas, P. Moreau et al., “Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications,” Journal of Clinical Oncology, vol. 29, no. 14, pp. 1893–1897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Zhan, Y. Huang, S. Colla et al., “The molecular classification of multiple myeloma,” Blood, vol. 108, no. 6, pp. 2020–2028, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. N. C. Gutiérrez, M. E. Sarasquete, I. Misiewicz-Krzeminska et al., “Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling,” Leukemia, vol. 24, no. 3, pp. 629–637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Maragkakis, P. Alexiou, G. L. Papadopoulos et al., “Accurate microRNA target prediction correlates with protein repression levels,” BMC Bioinformatics, vol. 10, article 295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Maragkakis, M. Reczko, V. A. Simossis et al., “DIANA-microT web server: elucidating microRNA functions through target prediction,” Nucleic Acids Research, vol. 37, no. 2, pp. W273–W276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Krek, D. Grün, M. N. Poy et al., “Combinatorial microRNA target predictions,” Nature Genetics, vol. 37, no. 5, pp. 495–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. C. Miranda, T. Huynh, Y. Tay et al., “A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes,” Cell, vol. 126, no. 6, pp. 1203–1217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Rehmsmeier, P. Steffen, M. Höchsmann, and R. Giegerich, “Fast and effective prediction of microRNA/target duplexes,” RNA, vol. 10, no. 10, pp. 1507–1517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. B. P. Lewis, I.-H. Shih, M. W. Jones-Rhoades, D. P. Bartel, and C. B. Burge, “Prediction of mammalian microRNA targets,” Cell, vol. 115, no. 7, pp. 787–798, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Enright, B. John, U. Gaul, T. Tuschl, C. Sander, and D. S. Marks, “MicroRNA targets in Drosophila,” Genome biology, vol. 5, no. 1, article R1, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Kertesz, N. Iovino, U. Unnerstall, U. Gaul, and E. Segal, “The role of site accessibility in microRNA target recognition,” Nature Genetics, vol. 39, no. 10, pp. 1278–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Kutalik, J. S. Beckmann, and S. Bergmann, “A modular approach for integrative analysis of large-scale gene-expression and drug-response data,” Nature Biotechnology, vol. 26, no. 5, pp. 531–539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Ashburner, C. A. Ball, J. A. Blake et al., “Gene ontology: tool for the unification of biology. The Gene Ontology Consortium,” Nature Genetics, vol. 25, no. 1, pp. 25–29, 2000. View at Google Scholar
  35. S. Zhang, C.-C. Liu, W. Li, H. Shen, P. W. Laird, and X. J. Zhou, “Discovery of multi-dimensional modules by integrative analysis of cancer genomic data,” Nucleic Acids Research, vol. 40, no. 19, pp. 9379–9391, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Zojer, R. Königsberg, J. Ackermann et al., “Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization,” Blood, vol. 95, no. 6, pp. 1925–1930, 2000. View at Google Scholar · View at Scopus
  37. V. Quidville, S. Alsafadi, A. Goubar et al., “Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy,” Cancer Research, vol. 73, no. 7, pp. 2247–2258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Li, N. Kon, L. Jiang et al., “Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence,” Cell, vol. 149, no. 6, pp. 1269–1283, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Serpico, L. Molino, and S. Di Cosimo, “microRNAs in breast cancer development and treatment,” Cancer Treatment Reviews, vol. 40, no. 5, pp. 595–604, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Wang, K.-Y. Zhang, S.-M. Liu, and S. Sen, “Tumor-Associated circulating micrornas as biomarkers of cancer,” Molecules, vol. 19, no. 2, pp. 1912–1938, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Mi, J. Lu, M. Sun et al., “MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 50, pp. 19971–19976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Zhang, X.-Q. Luo, P. Zhang et al., “MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia,” PLoS ONE, vol. 4, no. 11, Article ID e7826, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Venturini, K. Battmer, M. Castoldi et al., “Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells,” Blood, vol. 109, no. 10, pp. 4399–4405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Ronchetti, M. Lionetti, L. Mosca et al., “An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma,” BMC Medical Genomics, vol. 1, article 37, 2008. View at Publisher · View at Google Scholar
  45. N. Cloonan, M. K. Brown, A. L. Steptoe et al., “The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition,” Genome Biology, vol. 9, no. 8, article R127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Zhou, L. Chen, and B. Barlogie, “High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 7904–7909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Chesi, D. F. Robbiani, M. Sebag et al., “AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies,” Cancer Cell, vol. 13, no. 2, pp. 167–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Kim, A. J. Woo, J. Chu et al., “A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs,” Cell, vol. 143, no. 2, pp. 313–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Purushothaman and B. P. Toole, “Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization,” Journal of Biological Chemistry, vol. 289, no. 9, pp. 5499–5509, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. C. C. Bjorklund, V. Baladandayuthapani, H. Y. Lin et al., “Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications,” Leukemia, vol. 28, no. 2, pp. 373–383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. J. F. Curtin and T. G. Cotter, “JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells,” Journal of Biological Chemistry, vol. 279, no. 17, pp. 17090–17100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Kurehara, H. Ishiguro, M. Kimura et al., “A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients,” International Journal of Oncology, vol. 30, no. 2, pp. 421–428, 2007. View at Google Scholar · View at Scopus
  53. T. Shimbo, A. Tanemura, T. Yamazaki, K. Tamai, I. Katayama, and Y. Kaneda, “Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma,” PLoS ONE, vol. 5, no. 5, Article ID e10566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Avet-Loiseau, T. Facon, B. Grosbois et al., “Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation,” Blood, vol. 99, no. 6, pp. 2185–2191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Dring, F. E. Davies, J. A. L. Fenton et al., “A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma,” Clinical Cancer Research, vol. 10, no. 17, pp. 5692–5701, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Fonseca, C. S. Debes-Marun, E. B. Picken et al., “The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma,” Blood, vol. 102, no. 7, pp. 2562–2567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. J. J. Keats, T. Reiman, C. A. Maxwell et al., “In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression,” Blood, vol. 101, no. 4, pp. 1520–1529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Lionetti, M. Biasiolo, L. Agnelli et al., “Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma,” Blood, vol. 114, no. 25, pp. e20–e26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Bakkus, S. Dujardin, I. van Riet, and M. de Waele, “MicroRNA expression analysis in multiple myeloma plasma cells and cell lines by a quantitative real-time PCR approach,” Blood, vol. 110, abstract 2472, pp. 1330–1333, 2007. View at Google Scholar
  60. S. Adamia, H. Avet-Loiseau, S. B. Amin et al., “Clinical and biological significance of microRNA profiling in patients with myeloma,” Journal of Clinical Oncology, vol. 27, supplement 15, abstract 8539, 2009. View at Google Scholar
  61. M. Y. Murray, S. A. Rushworth, L. Zaitseva, K. M. Bowles, and D. J. MacEwan, “Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression,” Cell Cycle, vol. 12, no. 13, pp. 2144–2153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Unno, Y. Zhou, T. Zimmerman, L. C. Platanias, and A. Wickrema, “Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma,” Leukemia & Lymphoma, vol. 50, no. 11, pp. 1865–1871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. C. S. Chim, K. Y. Wong, Y. Qi et al., “Epigenetic inactivation of the miR-34a in hematological malignancies,” Carcinogenesis, vol. 31, no. 4, pp. 745–750, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Kumar, Z. Lu, A. A. L. Takwi et al., “Negative regulation of the tumor suppressor p53 gene by microRNAs,” Oncogene, vol. 30, no. 7, pp. 843–853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. K. H. Lim, A. T. Baines, J. J. Fiordalisi et al., “Activation of RalA is critical for Ras-induced tumorigenesis of human cells,” Cancer Cell, vol. 7, no. 6, pp. 533–545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Kameda, M. Watanabe, M. Bohgaki, T. Tsukiyama, and S. Hatakeyama, “Inhibition of NF-κB signaling via tyrosine phosphorylation of Ymer,” Biochemical and Biophysical Research Communications, vol. 378, no. 4, pp. 744–749, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Farfsing, F. Engel, M. Seiffert et al., “Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia,” Leukemia, vol. 23, no. 11, pp. 2018–2026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Zhao, S. Jin, and A. M. Gewirtz, “The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemia,” The Journal of Biological Chemistry, vol. 287, no. 2, pp. 925–934, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. Q. Jiang, Y. Wang, Y. Hao et al., “miR2Disease: a manually curated database for microRNA deregulation in human disease,” Nucleic Acids Research, vol. 37, no. 1, pp. D98–D104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. I. K. Guttilla and B. A. White, “Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells,” Journal of Biological Chemistry, vol. 284, no. 35, pp. 23204–23216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Lewis-Saravalli, S. Campbell, and A. Claing, “ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells,” Cellular Signalling, vol. 25, no. 9, pp. 1813–1819, 2013. View at Publisher · View at Google Scholar · View at Scopus